GCAD is funded by the NIA to harmonize relevant whole genome/exome sequencing data for the identification of risk/causative/protective genetic variants and eventual therapeutic targets for AD. GCAD is responsible for generating project-level sequence datasets, implementing quality control (QC) on them, and making them publicly available for research. The GCAD-QC working group meeting is used to discuss genomic data production, QC, and release progress.
